gonal-f 900 iu1.5 ml (66 mcg1.5 ml) solution for injection in a pre-filled pen
merck pte. ltd. - follitropin alfa - injection, solution - 66.69 mcg - follitropin alfa 66.69 mcg
bifiteral 66.7 g/100 ml syrup
viatris healthcare sa-nv - lactulose 66,7 g/100 ml - syrup - 66,7 g/100 ml - lactulose 666.66 mg/ml - lactulose
medijel gel 0.66%,0.05%w/w 0.66%w/w, 0.05%w/w
مستودع ادوية فزع - مستودع ادوية فزع - lidocaine hydrochloride 0.66 %w/w, aminoacridine hydrochloride 0.05 %w/w - 0.66%w/w, 0.05%w/w
rectolyn suppositories 66.6 mg, 3.3 mg, 66.6 mg, 66.6 mg
شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - paracetamol 66.6 mg, oxomemazine 3.3 mg, guaifenesin 66.6 mg, sodium benzoate 66.6 mg - 66.6 mg, 3.3 mg, 66.6 mg, 66.6 mg
actilax
viatris limited - lactulose 66%{relative} - syrup - 66% w/v - active: lactulose 66%{relative} - treatment of acute, and prevention and treatment of portal-systemic encephalopathy (pse), including the stages of hepatic precoma and coma.
duphalac
viatris limited - lactulose 66.7%{relative}; - syrup - 66.7% w/v - active: lactulose 66.7%{relative}
lactulose
viatris limited - lactulose 66%{relative}; - syrup - 66% w/v - active: lactulose 66%{relative}
medijel oromucosal gellidocaine hydrochloride 0.66% w/waminoacridine hydrochloride 0.05% w/w
d.d.d. limited - aminacrine hydrochloride; lignocaine hydrochloride - oromucosal gel - 0.66 %w/w +0.05 percent weight/weight - anesthetics for topical use; lidocaine; acridine derivatives
lactus syrup 66% wv
icm pharma pte. ltd. - lactulose - syrup - 66% w/v - lactulose 66% w/v
ipratropium bromide and albuterol sulfate solution
actavis pharma, inc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives. ipratropium bromide and albuterol sulfate inhalation solution 0.5 mg/3 mg per 3 ml read this patient information completely every time your prescription is filled as information may have changed. keep these instructions with your medication as you may want to read them again. ipratropium bromide and albuterol sulfate inhalation solution should only be used under the direction of a physician. your physician and pharmacist have more information about ipratropium bromide and albuterol sulfate inhalation solution and the condition for which it has been prescribed. contact them if you have additional questions. storing your medicine store ipratrop